Why Vasculitis Probably can be Ameliorated with Magnesium and Antagonists of Ceramides and Platelet-Activating Factor
Volume 3 - Issue 1
Burton M Altura1-7*, Asefa Gebrewold1,6, Anthony Carella1, Nilank C Shah1, Gatha J Shah1, Lawrence M Resnick8 and Bella T Altura1,3-7
-
Author Information
Open or Close
- 1Department of Physiology and Pharmacology, SUNY Downstate Medical Center, New York, USA
- 2Deparment of Medicine, SUNY Downstate Medical Center, New York, USA
- 3The Center for Cardiovascular and Muscle Research, SUNY Downstate Medical Center, New York, USA
- 4The School for Graduate Studies in Molecular and Cellular Science, The State University of New York Downstate Medical Center, Brooklyn, New York, USA
- 5Bio-Defense Systems, Inc, Rockville Centre, New York, USA
- 6Orient Biomedical Inc., Estero, Florida, USA
- 7Magnesium for Health Foundation, Patterson, California, USA
- 8Department of Medicine, Cornell University College of Medicine, New York, USA
*Corresponding author:
BM Altura, Department of Physiology and Pharmacology, SUNY Downstate Medical Center, New York, USA
Received:June 24, 2019; Published: July 02, 2019
DOI: 10.32474/SCSOAJ.2019.02.000153
Full Text
PDF
To view the Full Article Peer-reviewed Article PDF
Abstract
Vasculitis is characterized as an inflammatory disease of the body’s small blood vessels, particularly in the lungs and kidneys [1-4]. Many other organ regions are usually affected which often induces morbidity and mortality [1-4]. Although the exact causes of vasculitis are not known, it appears to be an autoimmune disease even though physical, chemical injuries and infections can result in vasculitis [1-4]
Introduction|
Conclusion|
Acknowledgement|
References|